Related Experiment Video
Updated: Apr 15, 2026
07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
Novel therapies for myelofibrosis
Brady L Stein1,2, Francisco Cervantes3, Francis Giles2
1a Northwestern University Feinberg School of Medicine , Chicago , IL , USA.
Leukemia & Lymphoma
|April 11, 2015
Summary
Myelofibrosis (MF) treatments are advancing beyond JAK inhibitors. Combining JAK inhibitors with novel therapies shows promise for reducing disease burden and improving patient outcomes in MF.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Myelofibrosis (MF) significantly impacts quality of life and survival.
- Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway dysregulation is a key feature in MF.
- Current JAK inhibitors manage symptoms but do not cure MF.
Purpose of the Study:
- To review novel therapeutic strategies for Myelofibrosis.
- To explore combination therapies targeting JAK inhibitors resistance.
- To identify additional therapeutic targets beyond the JAK/STAT pathway.
Main Methods:
- Literature review of current and emerging Myelofibrosis treatments.
- Analysis of therapeutic strategies targeting novel pathways.
- Discussion of combination therapies for Myelofibrosis.
Main Results:
- JAK inhibitors are effective for symptom control in MF.
- Combination therapies are being investigated to enhance efficacy and overcome resistance.
- Multiple novel targets are being explored, including epigenetic modulators and downstream signaling pathways.
Conclusions:
- Novel therapeutic strategies, including combination therapies, offer potential for improved Myelofibrosis management.
- Targeting additional pathways alongside JAK/STAT may reduce disease burden more effectively.
- Further research into novel agents and combinations is crucial for advancing MF treatment.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
02:50Combination Therapies and Personalized Medicine
1.9K
1.9K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:15Differentiation of Common Myeloid Progenitor Cells
4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K
01:21Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K